Medical Students Articles

Med Student

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Panettieri Jr RA et al. – In these subjects with moderate to severe COPD, single–day administrations of ARF15 BID or ARF30 QD were associated with FEV1 responses over a period of 24 hours that were considered equivalent per the protocol definition employed in the present study. FEV1 improvement over 12 hours was greater for ARF30 QD after the morning dose and for ARF15 BID after the evening dose.

Related Articles

Increased relative mortality in women with severe oxygen-dependent chronic obstructive pulmonary disease
Chest, 10/07/09    Relevance Score: 90%

Increased relative mortality in women with severe oxygen-dependent chronic obstructive pulmonary disease
Chest, 10/05/09    Relevance Score: 90%

Chronic Obstructive Pulmonary Disease
Internet Source, 10/30/09    Relevance Score: 89%

CAM and Respiratory Disease
Nutrition in Clinical Practice, 10/30/09    Relevance Score: 89%

The immediate effect of individual manipulation techniques on pulmonary function measures in persons with chronic obstructive pulmonary disease
Internet Source, 10/09/09    Relevance Score: 89%

Today in Family Medicine...keeping you current

Integration of sub-classification strategies in RCTs evaluating manual therapy treatment and exercise therapy for non-specific chronic low back pain (NSCLBP): a systematic review
British Journal of Sports Medicine, 12/11/09

Vitamin B12 and older adults
Current Opinion in Clinical Nutrition & Metabolic Care, 12/11/09

Age-related macular degeneration and antioxidant vitamins: recent findings
Current Opinion in Clinical Nutrition & Metabolic Care, 12/11/09

Today in Internal Medicine...keeping you current

Pneumonia Recovery; Discrepancies in Perspectives of the Radiologist, Physician and Patient
Journal of General Internal Medicine, 12/11/09

Migraine and Functional Impairment
CNS Drugs, 12/11/09

Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation
Core Evidence, 12/11/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address